Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 79

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1
Chunk 79
---
 or other intellectual property rights may not be effective or sufficient to prevent
them from competing.

Many
companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The
legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual
property protection, which could make it difficult for us to stop the infringement of our licensed patents and future patents we may
own, or marketing of competing products in violation of our proprietary rights generally. Further, the laws of some foreign countries
do not protect proprietary rights to the same extent or in the same manner as the laws of the U.S. As a result, we may encounter significant
problems in protecting and defending our licensed and owned intellectual property both in the U.S. and abroad. Proceedings to enforce
our future patent rights, if any, in foreign jurisdictions could result in substantial cost and divert our efforts and attention from
other aspects of our business.

We
may be unable to adequately prevent disclosure of trade secrets and other proprietary information.

In
order to protect our proprietary technology and processes, we rely in part on confidentiality agreements with our corporate partners,
employees, consultants, manufacturers, outside scientific collaborators and sponsored researchers and other advisors. These agreements
may not effectively prevent disclosure of our confidential information and may not provide an adequate remedy in the event of unauthorized
disclosure of confidential information. In addition, others may independently discover our trade secrets and proprietary information.
Failure to obtain or maintain trade secret protection could adversely affect our competitive business position.

52

We
may be subject to claims challenging the inventorship of our patents, any future patents we may own, and other intellectual property.

Although
we are not currently experiencing any claims challenging the inventorship of our patents or our owned intellectual property, we may in
the future be subject to claims that former employees, collaborators or other third parties have an interest in our patents or other
owned intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations
of consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and
other claims challenging inventorship. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable
intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could
have a material adverse effect on our business, financial condition and results of operations. Even if we are successful